Picture of Biotricity logo

BTCY — Biotricity News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Biotricity Inc reports results for the quarter ended in June - Earnings Summary

* Biotricity Inc  BTCY.OQ  reported a quarterly adjusted
loss
of 41 cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 41 cents per
share.
    * Revenue rose 46.9% to $3.02 million from a year ago;
analysts
expected $3.10 million. 
    * Biotricity Inc's reported EPS for the quarter was a loss
of 41
cents​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Biotricity Inc shares had fallen by 36.7% this quarter and
lost 10.0% so far this year.
    * The company reported a quarterly loss of $3.6 million.
    * Wall Street's median 12-month price target for Biotricity
Inc is
$4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 15 at 01:49 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.41          -0.41          Met
 Mar. 31 2023      -0.54          -0.54          Met
 Dec. 31 2022      -0.54          -0.54          Met
 Sep. 30 2022      -0.44          -0.56          Missed

Recent news on Biotricity

See all news